4-(4-(1,3,4-thiadiazol-2-yl)piperazin-1-yl)-6-ethylthieno[2,3-d]pyriMidine

4-(4-(1,3,4-thiadiazol-2-yl)piperazin-1-yl)-6-ethylthieno[2,3-d]pyriMidine Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

6-Ethyl-4-[4-(1,3,4-thiadiazol-2-yl)-1-piperazinyl]thieno[2,3-d]pyrimidine is an intermediate used in the synthesis of 6-Ethyl-4-[4-(1,3,4-thiadiazol-2-yl)-1-piperazinyl]thieno[2,3-d]pyrimidine Hydrochloride (E926745), which is an inhibitor of fusion protein interaction of menin-mixed lineage leukemia (menin-MLL). Menin-MLL inhibitors downregulate the expression of target genes required for MLL fusion protein oncogenic activity and thus effectively reverse MLL fusion protein-mediated leukemic transformation.

4-(4-(1,3,4-thiadiazol-2-yl)piperazin-1-yl)-6-ethylthieno[2,3-d]pyriMidine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

4-(4-(1,3,4-thiadiazol-2-yl)piperazin-1-yl)-6-ethylthieno[2,3-d]pyriMidine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Yancheng KangdiSen Pharmaceutical Co., Ltd.	13812573443	tongbenwan22@163.com	China	1982	55
Wuxi KaideRui Pharmaceutical Technology Co., Ltd	19906241957	1557216087@qq.com	China	1768	55
Wuxi Donghe Pharmaceutical Technology Co., Ltd.	63313187 15358055255	63313187@qq.com	China	1995	58

---

• 4-(4-(1,3,4-thiadiazol-2-yl)piperazin-1-yl)-6-ethylthieno[2,3-d]pyriMidine
• Thieno[2,3-d]pyrimidine, 6-ethyl-4-[4-(1,3,4-thiadiazol-2-yl)-1-piperazinyl]-
• 6-Ethyl-4-[4-(1,3,4-thiadiazol-2-yl)-1-piperazinyl]thieno[2,3-d]pyrimidine
• 1359873-35-0
• C14H16N6S2